Antivirals for treatment of HCV infections
- ATC Codes
- Antiinfectives for systemic use
- Antiviral drugs
- Direct acting antiviral drugs
- Antivirals for treatment of HCV infections
- J05AP01 : Ribavirin
- J05AP02 : Telaprevir
- J05AP03 : Boceprevir
- J05AP04 : Faldaprevir
- J05AP05 : Simeprevir
- J05AP06 : Asunaprevir
- J05AP07 : Daclatasvir
- J05AP08 : Sofosbuvir
- J05AP09 : Dasabuvir
- J05AP10 : Elbasvir
- J05AP11 : Grazoprevir
- J05AP12 : Coblopasvir
- J05AP51 : Sofosbuvir and ledipasvir
- J05AP52 : Dasabuvir, ombitasvir, paritaprevir and ritonavir
- J05AP53 : Ombitasvir, paritaprevir and ritonavir
- J05AP54 : Elbasvir and grazoprevir
- J05AP55 : Sofosbuvir and velpatasvir
- J05AP56 : Sofosbuvir, velpatasvir and voxilaprevir
- J05AP57 : Glecaprevir and pibrentasvir
- J05AP58 : Daclatasvir, asunaprevir and beclabuvir